85% accuracy in early Parkinson’s classification establishes Clinical ink as the industry leader in patient science and digital biomarkers.
Newsroom
JAMA publication demonstrates assessment validity, points to future research and real-world applications Horsham, Pa.; February 16, 2022 — Clinical ink, a global …
Attributes 293% Revenue Growth to technologies that simplify and accelerate complex clinical trial activities HORSHAM, Pa.; Nov. 17, 2021 (Business Wire) – …
Learn how Clinical ink's acquisition of Digital Artefacts will bring about the convergence of digital endpoints and outcome assessments.
Clinical ink CBO Jonathan Andrus Selected as DTRA Co-Leader Chosen to Head Decentralized Trials & Research Alliance Regulatory Gap Initiative Horsham, Pa.; …
New Role to Serve Rapidly Expanding Global Customer Base Horsham, Pa.; May 18, 2021 – Clinical Ink, a global clinical trial technology …
New Positions Created to Manage Dramatic Growth HORSHAM, Pa.; May 4, 2021 – Clinical Ink, a global clinical trial technology company, today …
HORSHAM, Pa.; April 20, 2021 – Clinical Ink, a global clinical trial technology company, today announced it has deployed an industry-leading 500 …
